155 related articles for article (PubMed ID: 10589246)
1. [The efficacy of the radioiodine treatment of toxic thyroid adenoma and multinodular goiter].
Gómez-Arnaiz N; Maravall J; Gómez JM; Gumà A; Andía E; Mora J
Rev Clin Esp; 1999 Oct; 199(10):637-40. PubMed ID: 10589246
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism.
Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F
J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406
[TBL] [Abstract][Full Text] [Related]
3. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment.
Wallaschofski H; Müller D; Georgi P; Paschke R
Horm Metab Res; 2002 Jan; 34(1):36-9. PubMed ID: 11833000
[TBL] [Abstract][Full Text] [Related]
4. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of radioiodine treatment on thyroid functions and ultrasonographic features in patients with toxic adenoma and toxic multinodular goitre.
Koç I; Bahçecioğlu AB; Avcı Merdin F; Araz M; Erdoğan MF
Ann Nucl Med; 2023 Jun; 37(6):371-379. PubMed ID: 37010726
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine treatment of multinodular non-toxic goitre.
Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM
BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123
[TBL] [Abstract][Full Text] [Related]
7. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity.
Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467
[TBL] [Abstract][Full Text] [Related]
8. [Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?].
Nygaard B; Faber JO; Hegedüs L
Ugeskr Laeger; 1995 Dec; 157(50):7003-6. PubMed ID: 8545918
[TBL] [Abstract][Full Text] [Related]
9. Acute changes in thyroid volume and function following 131I therapy of multinodular goitre.
Nygaard B; Faber J; Hegedüs L
Clin Endocrinol (Oxf); 1994 Dec; 41(6):715-8. PubMed ID: 7889605
[TBL] [Abstract][Full Text] [Related]
10. [F-18-FDG PET in autonomous goiter].
Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
Nuklearmedizin; 1999; 38(1):1-6. PubMed ID: 9987775
[TBL] [Abstract][Full Text] [Related]
11. 131I therapy of toxic and non-toxic goiters.
Beckers C
Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
13. Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters.
Szumowski P; Rogowski F; Abdelrazek S; Kociura-Sawicka A; Sokolik-Ostasz A
Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):7-13. PubMed ID: 23047567
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy.
Khanna CM; Magdam M; Ravishankar L; Dham DN; Chugh P
J Assoc Physicians India; 1995 Oct; 43(10):685-8. PubMed ID: 8773004
[TBL] [Abstract][Full Text] [Related]
15. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine treatment of Plummer and multinodular toxic and nontoxic goiter disease by the first approximation dosimetry method.
Zingrillo M; Urbano N; Suriano V; Modoni S
Cancer Biother Radiopharm; 2007 Apr; 22(2):256-60. PubMed ID: 17600473
[TBL] [Abstract][Full Text] [Related]
17. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
[TBL] [Abstract][Full Text] [Related]
18. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy.
Kahraman D; Keller C; Schneider C; Eschner W; Sudbrock F; Schmidt M; Schicha H; Dietlein M; Kobe C
Clin Endocrinol (Oxf); 2012 Feb; 76(2):297-303. PubMed ID: 21854403
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic results of radioiodine therapy of hyperthyroid thyroid gland diseases].
Debrand-Passard A; Barzen G; Richter W; Wenzel KW; Felix R
Med Klin (Munich); 1994 Jun; 89(6):319-23. PubMed ID: 8072455
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
